FIND tuberculosis strain bank: A resource for researchers and developers working on tests to detect mycobacterium tuberculosis and related drug resistance

Journal of Clinical Microbiology

Volumn 55, Issue 4, 2017, Pages 1066-1073

  Tessema, Belay ^a,b   Nabeta, Pamela ^a   Valli, Eloise ^a   Albertini, Audrey ^a   Collantes, Jimena ^c   Lan, Nguyen Huu ^d   Romancenco, Elena ^e   Tukavdze, Nestani ^f   Denkinger, Claudia M ^a   Dolinger, David L ^a  

^a FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^b UNIVERSITY OF GONDAR   (Ethiopia)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d Pham Ngoc Thach Hospital   (Viet Nam)

^e Phthisiopneumology Institute   (Moldova)

^f National Centre for Tuberculosis and Lung Disease   (Georgia)

Author keywords

Diagnostics development; Drug resistant tuberculosis; Strain bank

Indexed keywords

ETHIONAMIDE; GENOMIC DNA; KATG PROTEIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; CONTROLLED STUDY; DNA EXTRACTION; EIS GENE; EMBA GENE; EMBB GENE; ETHA GENE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENETIC VARIABILITY; GYRA GENE; GYRB GENE; INHA GENE; INTERSPERSED REPEAT; KATG GENE; MICROBIAL DIVERSITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNCA GENE; RPOB GENE; RRS GENE; TLYA GENE; VARIABLE NUMBER OF TANDEM REPEAT; WHOLE GENOME SEQUENCING; BIOBANK; CLINICAL TRIAL; DRUG EFFECTS; HUMAN; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

BIOLOGICAL SPECIMEN BANKS; DRUG RESISTANCE, BACTERIAL; HUMANS; INTERNATIONAL COOPERATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 85016179903     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01662-16     Document Type: Article

References (20)

1. World Health Organization. 2015. Global tuberculosis report 2015. 20th ed. World Health Organization, Geneva, Switzerland.
2. World Health Organization. 2014. Global strategy and targets for tuberculosis prevention, care and control after 2015. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/strategy/End-TB-Strategy.pdf.
3. World Health Organization. 2015. Implementing tuberculosis diagnostics: a policy framework. World Health Organization, Geneva, Switzerland.
4. World Health Organization. 2015. Guidelines for surveillance of drug resistance in tuberculosis. 5th ed. World Health Organization, Geneva, Switzerland.
5. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. https://doi.org/10.1016/0140-6736(93)90417-F.
6. Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo Elias C, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CL, Bowden R, Drobniewski FA, Allix-Béguec C, Gaudin C, Parkhill J, Diel R, Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Peto TE, Modernizing Medical Microbiology (MMM) Informatics Group. 2015. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15:1193-1202. https://doi.org/10.1016/S1473-3099(15)00062-6.
7. Starks AM, Avilés E, Cirillo DM, Denkinger CM, Dolinger DL, Emerson C, Gallarda J, Hanna D, Kim PS, Liwski R, Miotto P, Schito M, Zignol M. 2015. Collaborative effort for a centralized worldwide tuberculosis relational sequencing data platform. Clin Infect Dis 61(Suppl):S141-S146. https://doi.org/10.1093/cid/civ610.
8. Vincent V, Rigouts L, Nduwamahoro E, Holmes B, Cunningham J, Guillerm M, Nathanson CM, Moussy F, De Jong B, Portaels F, Ramsay A. 2012. The TDR tuberculosis strain bank: a resource for basic science, tool development and diagnostic services. Int J Tuberc Lung Dis 16:24-31. https://doi.org/10.5588/ijtld.11.0223.
9. Nathanson CM, Cuevas LE, Cunningham J, Perkins MD, Peeling RW, Guillerm M, Moussy F, Ramsay A. 2010. The TDR tuberculosis specimen bank: a resource for diagnostic test developers. Int J Tuberc Lung Dis 14:1461-1467.
10. Denkinger CM, Dolinger D, Schito M, Wells W, Cobelens F, Pai M, Zignol M, Cirillo DM, Alland D, Casenghi M, Gallarda J, Boehme CC, Perkins MD. 2015. Target product profile of a molecular drug-susceptibility test for use in microscopy centers. J Infect Dis 211(Suppl):S39-S49. https://doi.org/10.1093/infdis/jiu682.
11. International Society for Biological and Environmental Repositories. 2012. 2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories. Biopreserv Biobank 10: 79-161. https://doi.org/10.1089/bio.2012.1022.
12. World Health Organization. 2014. High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. World Health Organization, Geneva, Switzerland.
13. World Health Organization. 2012. Updated interim critical concentrations for first-line and second-line DST (as of May 2012). World Health Organization, Geneva, Switzerland.
14. Springer B, Lucke K, Calligaris-Maibach R, Ritter C, Böttger EC. 2009. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J Clin Microbiol 47: 1773-1780. https://doi.org/10.1128/JCM.02501-08.
15. Cambau E, Viveiros M, Machado D, Raskine L, Ritter C, Tortoli E, Matthys V, Hoffner S, Richter E, Perez Del Molino ML, Cirillo DM, van Soolingen D, Bottger EC. 2015. Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study. J Antimicrob Chemother 70:686-696. https://doi.org/10.1093/jac/dku438.
16. Feuerriegel S, Schleusener V, Beckert P, Kohl TA, Miotto P, Cirillo DM, Cabibbe AM, Niemann S, Fellenberg K. 2015. PhyResSE: a web tool delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data. J Clin Microbiol 53:1908-1914. http://www.ncbi.nlm.nih.gov/pubmed/25854485. https://doi.org/10.1128/JCM.00025-15.
17. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44:4498-4510. https://doi.org/10.1128/JCM.01392-06.
18. Homolka S, Projahn M, Feuerriegel S, Ubben T, Diel R, Nubel U, Niemann S. 2012. High resolution discrimination of clinical Mycobacterium tuberculosis complex strains based on single nucleotide polymorphisms. PLoS One 7:e39855. https://doi.org/10.1371/journal.pone.0039855.
19. Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, Eyre DW, Wilson DJ, Hawkey PM, Crook DW, Parkhill J, Harris D, Walker AS, Bowden R, Monk P, Smith EG, Peto TE. 2013. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13:137-146. https://doi.org/10.1016/S1473-3099(12)70277-3.
20. Bloom BR. 1994. Tuberculosis: pathogenesis, protection, and control. ASM press, Washington, DC.